Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Bolt Biotherapeutics (BOLT) Asset Utilization Ratio (2021 - 2025)

Bolt Biotherapeutics' Asset Utilization Ratio history spans 5 years, with the latest figure at 0.07 for Q3 2025.

  • For Q3 2025, Asset Utilization Ratio fell 11.74% year-over-year to 0.07; the TTM value through Sep 2025 reached 0.07, down 11.74%, while the annual FY2024 figure was 0.06, 45.88% up from the prior year.
  • Asset Utilization Ratio for Q3 2025 was 0.07 at Bolt Biotherapeutics, up from 0.05 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.08 in Q3 2024 and bottomed at 0.0 in Q1 2021.
  • The 5-year median for Asset Utilization Ratio is 0.04 (2023), against an average of 0.04.
  • The largest annual shift saw Asset Utilization Ratio skyrocketed 1889.85% in 2022 before it plummeted 47.58% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.0 in 2021, then surged by 493.42% to 0.02 in 2022, then skyrocketed by 94.16% to 0.05 in 2023, then skyrocketed by 56.59% to 0.07 in 2024, then rose by 0.44% to 0.07 in 2025.
  • Per Business Quant, the three most recent readings for BOLT's Asset Utilization Ratio are 0.07 (Q3 2025), 0.05 (Q2 2025), and 0.04 (Q1 2025).